Current treatment status-Undergoing active treatment-Progressive despite treatment - Page 26 of 29 Posts on Medivizor
Navigation Menu

Current treatment status-Undergoing active treatment-Progressive despite treatment Posts on Medivizor

Erlotinib with pemetrexed and cisplatin for lung cancer that has spread to the brain

Erlotinib with pemetrexed and cisplatin for lung cancer that has spread to the brain

Posted by on May 19, 2015 in Lung cancer | 0 comments

In a nutshell The objective of this study was to evaluate the effect of erlotinib (Tarceva) in combination with pemetrexed (Alimta) and cisplatin (Platinol) in lung cancer that had spread into the brain (brain metastases). Some background Lung adenocarcinoma is the cancer of glandular cells of lungs. It is a common type of non-small cell lung...

Read More

Pembrolizumab versus ipilimumab in advanced melanoma

Pembrolizumab versus ipilimumab in advanced melanoma

Posted by on May 19, 2015 in Melanoma | 0 comments

In a nutshell The authors aimed to evaluate survival benefits of pembrolizumab (Keytruda) compared to ipilimumab (Yervoy) in advanced melanoma. Some background In the advanced stage of melanoma (stage III/IV), cancer spreads from the skin to other parts of the body. One of the standard treatments for advanced melanoma is immunotherapy that uses...

Read More

Proteins can predict bone tumors and survival in hormone-resistant prostate cancer

Proteins can predict bone tumors and survival in hormone-resistant prostate cancer

Posted by on Apr 24, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine whether specific proteins can predict bone tumors and death in patients with hormone-resistant prostate cancer.  Some background In advanced prostate cancer, tumors can spread out from the initial site of cancer to other parts of the body and bones, making treatment difficult. Hormone therapy...

Read More

Nivolumab treatment for malignant skin cancer

Nivolumab treatment for malignant skin cancer

Posted by on Apr 8, 2015 in Melanoma | 0 comments

In a nutshell The authors aimed to determine the effect of nivolumab in treating malignant skin cancer.  Some background Nivolumab (Opdivo) is a man-made immune cell made to attack a specific disease that has been approved for treating malignant skin cancer (cancer that has spread throughout the body). Nivolumab functions by attaching to a...

Read More